SHWZ Medicine Man


Data from SEC filings
Employee count

ESG framework mentions

In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On December 9, 2021, Medicine Man Technologies, Inc. (the “Company”) held its 2021 Annual Meeting of Stockholders (the “Annual Meeting”). The matters voted upon and the results of the vote are set forth below.

Proposal 1: Election of Directors.

The Company’s stockholders elected all nominees named in the proxy statement for the Annual Meeting to the Company’s board of directors, each to serve as a Class B director for a two-year term expiring at the Company’s annual meeting of stockholders to be held in 2023 and until his successor is elected and qualified, or until his earlier death, resignation or removal, with the following vote:

ForAgainstAbstainBroker non-votes
Justin Dye61,446,316198,25431,34811,664,313
Pratap Mukharji61,461,035171,51243,37111,664,313
Brian Ruden61,458,234167,96649,78111,664,313

Proposal 2: Ratification of Appointment of Independent Public Accountant.

The Company’s stockholders ratified the appointment of BF Borgers, CPA P.C. as the Company’s independent public accountant for the fiscal year ending December 31, 2021, with the following vote:

ForAgainstAbstainBroker non-votes